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Necrotizing enterocolitis (NEC) is a leading cause of premature newborn
morbidity and mortality. The clinical features of NEC consistently include
prematurity, gut dysbiosis and enteral inﬂammation, yet the pathogenesis
remains obscure. Herein we combine metagenomics and targeted
metabolomics, with functional in vivo and in vitro assessment, to deﬁne
a novel molecular mechanism of NEC. One thousand six hundred and forty
seven publicly available metagenomics datasets were analyzed (NEC =
245; healthy = 1,402) using artiﬁcial intelligence methodologies. Targeted
metabolomic proﬁling was used to quantify the concentration of speciﬁed
fecal metabolites at NEC onset (n = 8), during recovery (n = 6), and in age
matched controls (n = 10). Toxicity assays of discovered metabolites were
performed in vivo in mice and in vitro using human intestinal epithelial
cells. Metagenomic and targeted metabolomic analyses revealed signiﬁcant
differences in pyruvate fermentation pathways and associated intermediates.
Notably, the short chain fatty acid formate was elevated in the stool of
NEC patients at disease onset (P = 0.005) dissipated during recovery (P =
0.02) and positively correlated with degree of intestinal injury (r2 = 0.86).
In vitro, formate caused enterocyte cytotoxicity in human cells through
necroptosis (P < 0.01). In vivo, luminal formate caused signiﬁcant dose and
development dependent NEC-like injury in newborn mice. Enterobacter
cloacae and Klebsiella pneumoniae were the most discriminatory taxa related
to NEC dysbiosis and increased formate production. Together, these data
suggest a novel biochemical mechanism of NEC through the microbial
production of formate. Clinical efforts to prevent NEC should focus on
reducing the functional consequences of newborn gut dysbiosis associated
metabolic pathways.
KEYWORDS

necrotizing enterocolitis (NEC), microbiome, formate, metagenomics, artiﬁcial
intelligence, dysbiosis, probiotics
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Importance

Metagenomic sequencing has been increasingly used to
better understand human colonizing microbiota and their
functional potential in a variety of clinical settings, including
hospitalized premature newborns (8, 12, 13). These approaches
have revealed the effects of various perinatal exposures including
antibiotics on the microbiota compositions and associated
antibiotic resistance genes (14, 15). The absence of species
level taxonomic classification and functional annotation of
specific pathways and metabolites in association with NEC is
an under-explored area of investigation. Thus, we recognized an
opportunity to apply state-of-the-art sequencing and annotation
techniques to functionally assess the microbiota at high
resolution (gene and species level) in order to determine the
degree to which microbe specific pathology may be biochemical
in nature. Accordingly, in this study we sought to determine the
relationship between NEC and the potential biochemical output
of host-microbe-pathogenicity interactions as reflected in the
metagenome, thus supporting a causal relationship between
specific microbial bioproducts and NEC. Since the predominant
product of microbiota fermentation of enterally provided
substrates is organic acids, we further sought to determine if
there was a significant shift in fecal stream short chain fatty
acids (SCFA) associated with NEC that could precipitate enteric
mucosal injury typical of NEC.

Necrotizing enterocolitis (NEC) is a leading cause of
premature newborn morbidity and mortality, and correlated
with enteric dysbiosis and inflammation; however, the
pathogenesis remains obscure. Here, we utilized publicly
available metagenomic sequences and proprietary targeted
metabolomics combined with functional in vivo and in vitro
assessment, to define a novel molecular mechanism of NEC.
Importantly, our analyses revealed a functional consequence
of the metabolic capacity of newborn gut dysbiosis as a novel
target for clinical efforts in premature infant care.

One sentence summary
In newborns with NEC, enteric dysbiosis confers
the metabolic capacity for enteric injury through altered
fermentation patterns.

Introduction
Necrotizing Enterocolitis (NEC) remains a leading cause
of premature newborn morbidity and mortality (1–3). Despite
decades of fundamental and clinical research, the precise
pathogenesis of NEC remains elusive. NEC has been most
durably associated with degree of prematurity, enteral feeding
and intestinal dysbiosis favoring Proteobacteria predominant
colonization, as well as the alteration in bacterial metabolites
including short chain fatty acids (SCFA) (4–7). Furthermore,
despite the well-documented presence of intestinal dysbiosis
preceding NEC onset in longitudinal studies (5), a specific
causal mechanism linked to distinct bacterial taxa has not
been established. Dysbiosis in premature newborns leading to
NEC has largely been characterized as absence of colonizing
microbial heterogeneity, loss of specific taxa abundance and
relative over-abundance of specific Enterobacteraceae species.
Indeed, an abundance of newborn microbiome literature
documents either altered microbiota diversity or aberrant
bacterial taxonomy in association with specific disease states
(8–11). It has become increasingly clear that gut dysbiosis is
associated with various pathologies including NEC, but specific
bacteria have not proven causative despite a variety of potential
pathogenic features. Together, these observations represent
an important gap in our understanding of the functional
significance of premature newborn dysbiosis and suggest a
still to be identified mechanism of pathophysiology conferred
by colonizing microbes. Considering that most cases of NEC
are observed in premature newborns that are being fed, one
intriguing hypothesis that we sought to explore is that inciting
pathologic features arise at the intersection of colonizing enteric
microbial function and host features producing a biochemical
pattern capable of producing enteric injury consistent with NEC.

Frontiers in Pediatrics

Results
Machine learning revealed NEC
microbiome signatures by
post-menstrual age
A total of 1,603 and 1,601 publicly available samples were
selected after quality filtering for taxonomic and functional
annotation, respectively (see methods). The largest dataset
produced represented a matrix of 11,026,566 (UniRef90 hits)
× 1,603 (samples; 245 NEC positive, 1,358 non-NEC) or
17.7 billion entries. Gene family entries were also converted
into pathways. By default, HUMAnN2 uses MetaCyc pathway
definitions and MinPath to identify a parsimonious set of
pathways that explain observed reactions in the community.
This led to a matrix of 1,601 (samples) × 595 (pathways) or 952.5
thousand entries. The microbial species identified in all samples
were, in total, 4,786 (Supplementary Table 1).
For analysis, the sample size was divided into different
subsets based on patient post menstrual age (PMA) at collection
and machine learning techniques were applied to assess whether
NEC or healthy preterm status could be predicted based on
microbiome signatures.
First, models were trained at all taxonomic levels (phylum
to species) and at several PMA combinations, which showed a
moderate increase in sensitivity in models trained on samples
with PMA >29 weeks (Supplementary Figures 1, 2). The model
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that performed the best was at the species level with samples >29
weeks PMA (testing accuracy = 0.9; precision = 0.24), a result
that was similar to previously published NEC models (16).
Next, we applied machine learning at the pathway level
obtained from HUMAnN2 (see methods), testing pathway
trends with or without the species stratification (e.g., a
combination of all species to the same pathway or the same
pathway considered as separate feature equal to the number of
unique species contributing to that pathway). Sixteen different
models were constructed on the significant pathways identified
with the Gini-importance score varying between stratified vs.
unstratified, balanced vs. unbalanced, and model architectures
(Figure 1A). For these models the inputs were both stratified
(n = 18,442 features) and unstratified (n = 597 features)
microbial pathways and tested at both a PMA < 29 or ≥
29 weeks, using balanced and unbalanced subsets for the
minority class (NEC) and using random forest or gradient
boosting classifiers (Figure 1A). The top performing models
able to classify NEC at a higher specificity and sensitivity at
the pathway levels, were all those with samples ≥29 PMA.
Specifically, the best overall model was derived from a gradient
booster classifier that had a combination of a balanced minority
class, was taxonomically stratified, and had only ≥29 PMA
(Figure 1A).
Based on the results obtained from the statistical analysis of
taxonomy and pathways, we selected a subset of samples with a
PMA ≥ 29 weeks for downstream analysis, which led to a total
of 561 samples (NEC = 88).

suggesting there are specific KO-species combinations that differ
by disease status that otherwise would be masked by collapsing
the data into a single KO derived from multiple species.
For exploratory purposes, we used Principal Component
Analysis (PCA) derived from a Bray-Curtis dissimilarity
matrix to explore the 573 stratified KO-species features set
(Figure 1B). Clustering by NEC status was significant on the
PCA plot, however with a low effect-size (P = 0.001; R2 =
0.05, Adonis).

Discriminatory taxa support a known role
for proteobacteria
We applied a ranking technique to the significant
unstratified UniRef90 entries (n = 3,420; see methods)
resulting in a hierarchy of 300 highly discriminatory
proteins (training accuracy = 0.992; testing accuracy
= 0.988) according to disease status. When stratifying
by species level taxonomy, these 300 UniRef90 proteins
corresponded to 834 features, with 108 unique bacterial
species carrying those proteins. We then tested a new
Random Forest model trained on this dataset yielding 1.0,
1.0, and 0.8 recall on training, testing and validation datasets,
respectively. A list of top bacterial species (n = 42) having
at least a count of 2 discriminatory proteins is reported in
Figure 2.
The top ranked bacterial species were mostly composed of
Enterobacteriaceae, including the top three ranked species by
mean relative abundance, Enterobacter cloacae (14% (NEC); 5%
(control)), Klebsiella pneumoniae (19%; 6%), and Staphylococcus
aureus (3%; 1%), which were all on average more than 3-fold
higher in the NEC cohort compared to controls (Figure 3A). E.
cloacae harbored the highest number of discriminatory proteins
(n = 58 or 10%) between NEC and controls, followed by K.
pneumoniae (n = 50 or 8%) and Staphylococcus aureus (n = 28
or 5%). Taken together, these three species were responsible for
carrying 22.8% of the total identified discriminatory proteins;
however, most of the UniRef90 proteins (n = 269 or 45%),
were associated with an uncharacterized taxonomy given the
proteins were identified via translated search and thus could
potentially belong to multiple species. Importantly, the majority
of the species in the top ranking were all taxa associated
with previously identified signatures of gut dysbiosis, known
to harbor virulence factors as well as antibiotic resistance
genes in the early-life microbiome (14, 17). These same
species have been shown to contribute to the nosocomial
microbiome and therefore potentially colonizing patients at-risk
for NEC (8, 15). Conversely, top ranking proteins that were
higher in controls were mostly species within the Bacteroides
genus, which were often undetected in samples from patients
with NEC.

Diversity analysis based on functional
modeling
After
considering
taxonomy
and
pathway
(Supplementary Figure 2), we next focused on the lowest
level of classification obtainable from metagenomics data (i.e.,
UniRef90 proteins). Since the UniReF90 ≥ 29 weeks PMA
were still 4.7 million unstratified proteins, in order to reduce
dimensionality and given that there is no previous indication of
which microbial feature should be over or under abundant in
NEC compared to preterm controls, we used a Kruskal-Wallis
test coupled with Bonferroni correction to determine the subset
of microbial proteins that were significantly different between
NEC and controls. From the Kruskal-Wallis test we selected
entries with an adjusted P < 0.0001 (Bonferroni), resulting in
3,420 unstratified UniRef90 proteins, which were converted
to KEGG orthologs (KO) in a stratified way, meaning that
the same ortholog gene could be associated to a different
species and kept as a separate feature. Initially, this led to
136,538 unique KO-species feature combinations, of which only
573 had an adjusted P < 0.0001 (Bonferroni) between study
groups. Critically, 569 KO-species combinations were unique,
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FIGURE 1

Machine learning revealed NEC microbiome signatures by post-menstrual age. (A) Pathway level data was stratiﬁed by species, oversampled to
balance NEC classes, sub-setted by PMA, and trained on different model algorithms to explore model performance. Models sub-setted to
include only samples from subjects with a PMA ≥29 weeks performed moderately better with respect to speciﬁcity and sensitivity than their
counterparts. (B) Principal coordinate analysis (PCoA) of all samples based on weighted UniFrac distance and colored by Necrotizing
Enterocolitis (NEC) or preterm infants without NEC (Preterm).

Speciﬁc changes in functional pathways
are more critical than taxonomy alone

focused on downstream analysis for the pathway level at ≥29
weeks PMA with stratification in order to discriminate related
bacterial species. We selected the top combination of pathwayspecies based on increasing Gini importance (Figure 3A). Given
the importance of microbe and enteral feedings in newborns
with NEC, we sought to determine if there were potential
metabolic differences associated with the NEC metagenomes
that were specific to the identified taxonomic changes. Notably,

In order to determine the relationship between taxonomy
and associated metagenome conferred biologic functions, Mean
Decrease in Accuracy was calculated for all features at the
pathway level for the top model (stratified pathways, PMA ≥ 29,
gradient boosting classifier, and balanced NEC classes). We
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FIGURE 2

Diversity analysis based on functional modeling. A histogram of proteins grouped by their respective species.

significantly different pathways at the species levels did not hold
significance at the genus level, which reinforced the concept that
there is a specific molecular signature through a combination
of species and pathways that points to a trend in specific
organic acid fermentation pathways (Figure 3B). Specifically,
within the Klebsiella pneumoniae associated pathways there was
a significantly increased number of represented genes in NEC
samples compared to controls (Supplementary Table 1). Given
these genes govern pyruvate fermentation to isobutanol as well
as acetate and lactate it was suggestive of increased metabolic
potential for SCFA conversion in the NEC patients compared
to controls.

fermentation in the gut. In order to identify significant shifts in
the newborn fecal stream metabolic pattern uniquely associated
with NEC onset and recovery, we quantified organic acids
and major SCFAs in fecal samples from non-ill premature
infants or those with NEC (Table 1). Intriguingly, we found
that the concentration of fecal formic acid (formate) was
significantly elevated in NEC patients at disease onset (4.40
± 3.52 umol/g) compared to gestational aged matched and
non-ill premature newborns (0.65 ± 0.90 umol/g; P = 0.005)
(Figure 4A). Intriguingly, formate levels returned to baseline
during recovery from NEC (0.61 ± 0.56 umol/g; P = 0.024)
and upon resumption of stooling in effected newborns. To
determine if changes in fecal organic acid concentrations
correspond to degree of intestinal injury, fecal cytokeratin 8
(K8) was measured in the same fecal samples in which the
organic acids were analyzed. Since keratin is only expressed by
sloughed and or dead enteric epithelial cells (mucosa), K8 is
a quantitative biomarker of intestinal injury and epithelial cell
specific loss (18). The concentrations of fecal formate strongly
correlated (r2 = 0.8655) with the level of keratin 8 (K8; control
group 18.0–65.7 ug/ml, NEC group 90.7–176.0 ug/ml; recovery
group 21.7–36.2 ug/ml) indicating the relationship between
formate and severity of intestinal epithelial damage (Figure 4B).
Given the observation of a significant increase in fecal formate

Metabolic changes associated with
metagenomic functional pathways in the
newborn fecal stream
The ability to degrade and ferment various enteral carbon
sources is one of the defining characteristics of competing
microbiomes; therefore, we reasoned that the functional
metagenomic shifts described above would be associated with
significant shifts in major organic acid by-products of microbial

Frontiers in Pediatrics

05

frontiersin.org

Casaburi et al.

10.3389/fped.2022.893059

FIGURE 3

Discriminatory taxa support a known role for proteobacteria. (A) Log2 fold change of discriminatory stratiﬁed pathways ordered by decreasing
gini importance. Red indicates log2 fold change higher in NEC samples and blue indicates log2 fold change higher in control samples. (B)
Kruskal-wallis tests were run between NEC and control samples for relative abundances of selected pathways from klebsiella pneumoniae. The
*, **, and *** symbols indicate P < 0.01, P < 0.01, and P < 0.001 respectively.

enzyme in mixed acid fermentation of pyruvate (Figure 7),
was 2–3 times more abundant (counts per million, NEC vs.
control) in NEC patients than control and was significantly
associated with Klebsiella pneumoniae (P = 0.02; FDR) and

associated with NEC, we re-examined specific KO proteins in
pyruvate metabolism and formate production as suggested by
the analysis above (Figure 3B). We noted that pyruvate formate
lyase (PFL) (KEGG: KO0656; EC 2.3.1.54), the rate limiting
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TABLE 1 Formic acid uniquely elevated in fecal samples of human newborns with NEC.

Healthy control
(µmole/gram of stool) Mean

SD

NEC on-set
Mean

SD

NEC recovery
Mean

SD

p

p

NEC on-set vs. control NEC on-set vs. recovery

Glycolic acid

1.542

0.464

1.370

0.128

2.704

2.124

0.287

0.185

Lactic acid

4.835

6.366

2.712

2.275

5.525

11.224

0.347

0.570

Formic acid

0.651

0.900

4.399

3.518

0.608

0.559

0.020**

0.019**

Acetic acid

7.917

3.491

9.413

3.463

9.003

1.975

0.378

0.785

Propionic acid

0.688

0.509

0.964

0.868

1.036

1.356

0.442

0.913

Isobutyric Acid

0.070

0.133

0.001

0.001

0.161

0.190

0.135

0.094

Butyric acid

0.204

0.132

2.089

5.494

0.570

0.765

0.364

0.464

Succinic acid

5.691

10.453

4.273

3.055

4.709

4.821

0.691

0.851

Valeric acid

0.105

0.127

0.136

0.242

0.037

0.010

0.746

0.286

indole-3-lactic acid

0.018

0.058

0.000

0.000

0.000

0.000

0.343

na

indole-3-acetic acid

0.055

0.054

0.019

0.003

0.032

0.025

0.066

0.249

indole-3-propionic acid

0.149

0.057

0.113

0.003

0.115

0.004

0.073

0.307

Hexanoic acid

0.353

0.100

1.160

1.939

0.344

0.064

0.277

0.273

indole-3-butyric acid

0.256

0.026

0.239

0.001

0.240

0.002

0.075

0.273

Pyruvic acid

0.771

0.393

0.714

0.564

0.608

0.311

0.815

0.660

**p < 0.05, statistic significance.

Enterobacter cloacae (P = 3.48 × 10−7 ; FDR), the leading
species associated with NEC. Thus, reinforcing the concept that
bacterial species-specific functions may represent the defining
attributes of Enterobacteriaceae dysbiosis in the pathophysiology
of NEC.

cell survival rate (Figure 5A) and cytotoxicity as measured by
lactate dehydrogenase (LDH) release (Figure 5B). Importantly,
the toxicity effect appeared to be specific to formate as parallel
studies using common fermentation organic acid products in the
newborn gut, including acetic acid (AA) and lactic acid (LA), did
not result in any measurable cellular toxicity in contrast to that
observed with formate (data not shown).
Given the known mechanism of formate in un-coupling
the electron transport chain with consequent effects on cellular
respiration (20, 21), cellular ATP production was serially
measured in HIEC-6 cells in response to formate (Sodium
Formate) exposure. A significant reduction in cellular ATP
production was observed with the most pronounced to 65.9%
of control group (P = 0.0018) at 6 h of exposure at 150 mM
of formate (Figure 5C). Since a reduction in gut barrier
integrity has been critically linked to NEC onset (22, 23),
we next tested the effect of formate on gut barrier function
using monolayer HIEC6 cells and transepithelial electrical
resistance (TEER) testing. Here, we observed a significant
reduction in gut barrier function from 105.0 to 66.7  •
cm2 within 30 min of exposure (P = 0.0012) with continued
compromise (51.3  • cm2; P = 0.0003) for up to 6 h
of exposure to 50 mM of formate, which corresponded to
the early peak reduction in ATP production (Figures 5C,D).
ATP reduction and barrier integrity disruption were also
associated with a significant reduction in phosphorylated
AKT and increased phosphorylated-mixed lineage kinase
domain-like protein p-MLKL (Supplementary Figure 3), known
to promote necroptosis-induced inflammation and loss of
enterocyte integrity (24, 25). Taken together, these data suggest

Formate-induced intestinal epithelial
injury and barrier compromise
Formate is a common bacterial fermentation end-product
liberated upon pyruvate conversion to acetyl-CoA by pyruvate
formate lyase (PFL). Increased formate end-product has
been associated with Enterobactereaceae predominant bacterial
blooms in human colitis and mouse models of inflammatory
colitis (19). As many fermentation products are produced
by colonizing bacteria, many of these organic acids are
either processed by the host typically as a fuel source or
potential mediator, or conversely further oxidized by specific
Enterobacteriaceae carrying terminal oxidases in the presence of
increased mucosal oxygen present during colonic inflammation.
Accordingly, we sought to determine the effects of formate on
intestinal epithelium independent of the presence of potentially
oxidizing microbes. Here, the cellular effects of formate on
human intestinal epithelial cells (HIEC6) were examined in
a dose and time dependent manner. Specifically, enterocyte
exposure to sodium formate in vitro resulted in a dose dependent
and significant increase in cell death as early as 6 h with toxic
effects continuing cumulatively for up to 72 h at all tested doses
(17, 50, and 150 mM). The cellular response was quantified as
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FIGURE 4

Elevated levels of formic acid (or formate anion) found in fecal specimens of human neonates with NEC. Fecal samples were collected from
human preterm neonates and used for mass spectrometric SCFAs assay and K8 ELISA assay. (A) The comparison of fecal formate in control and
NEC patients (onset and recovery) was performed with unpaired t-test. The concentration of fecal formate is signiﬁcantly elevated in NEC
patients at disease onset compared to non-ill premature newborns and formate levels return to baseline during recovery from NEC (P < 0.05).
(B) The relationship of fecal formate and K8 was analyzed by linear regression test (r2 = 0.8877).

formate vs. 0.86 ± 0.77 baseline, P < 0.01) and 28d (1.89 ±
1.10 vs. 0.43 ± 0.65, P < 0.01) mouse ileum, with a significant
increased overall NEC score in the 14 day mouse ileum (2.79
± 0.98 in 14d vs. 1.89 ± 1.10 in 28d, P < 0.05) reflecting
the histologic picture and corresponding to the fecal K8 levels
(Figure 6C).

a mechanism in which formate can induce necroptotic cellular
death supportive of previous observations associated with
NEC (25).

NEC-like intestinal injury in newborn
mice after formate treatment

Discussion

In order to test the effects of formate on intestinal integrity
in vivo, a mouse model comparing weaning (14 day) and weaned
(28 day) newborn mice were utilized. Prior publications have
described the developmental stage-dependent changes in mouse
gut morphology and function upon comparison of 14d and
28d mouse testing (26–29). Accordingly, 14d and 28d mice
underwent direct intraluminal injection of formate into the
terminal ileum in order to mimic the distribution of NEC injury
at one of two different doses (150 and 300 mM) and were
euthanized for assessment at 24 h of exposure. A significant
dose and developmental stage-dependent gut injury response
was observed at 24 h (Figures 6A,B). Notably, the degree of
injury, as determined by total fecal K8 levels, was markedly and
significantly increased in the 14d (56.1 ± 21.1 vs. 525.6 ± 73.3
ug/ml; n = 11) compared to the 28d (37.1 ± 7.0 vs. 162.9 ± 53.3
ug/ml; n = 8) mouse gut (P = 0.00072), respectively (Figure 6A).
Specifically, the histological appearance of the ileum in the 14d
mouse reflected an overall increased injury pattern, evidenced
by significant crypt-villus axis disruption, sloughed mucosa and
numerous dead cells with karyolysis, while shedding from villi to
the lumen was accompanied by an overall shortening of effected
villi (Figure 6B). Blinded pathologic assessment and grading
of the epithelial injury pattern according to the previously
described NEC score (Supplementary Table 2) (30), revealed a
significant increased injury pattern in both 14d (2.79 ± 0.98 after

Frontiers in Pediatrics

The present study is the first to our knowledge to
demonstrate a link between premature newborn gut dysbiosis,
the acquired newborn disease Necrotizing Enterocolitis (NEC)
and a mechanism of biochemical mediated intestinal injury
conferred through microbial fermentation and the overproduction of formate (Figure 7). This work extends prior
observations by explaining the biochemical consequences of
the documented wide-spread Proteobacteria predominant gut
colonization patterns preceding NEC in NICU hospitalized
premature newborns (5, 11, 26). The functional metagenomic
modeling herein provides evidence to support the previously
identified 29–32-week post-menstrual age window of peak NEC
susceptibility and onset (4). Specifically, the observation of
significantly enriched Enterobacteraceae species and associated
metabolic pathways resulting from their respective genomes
in premature newborns with NEC is most pronounced in
the designated PMA range providing a plausible biological
explanation for this heretofore unexplained observation.
Moreover, increased formate production quantified in the
stool of newborns with NEC along with the cellular and
intestinal injury caused by formate through the arrest of
cellular respiration and gut barrier disruption provide a
pathophysiologic mechanism of action linking the dysbiotic gut
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FIGURE 5

Formate causes intestinal epithelial injury and barrier dysfunction in vitro. Effect of Formate on HIEC-6 cells was determined using trypan blue
cell viability (A) and LDH cytotoxicity assay (B) at indicated concentrations and time-points. (C) Formate inhibits the production of ATP. (D)
Formate impairs the integrity of intestinal monolayer epithelial cells derived from hIESCs as measured by permeability. The * symbol indicates
the value of p < 0.05.

breast milk (HBM) is composed of human milk oligosaccharides
(HMOs) that cannot be digested by newborns. HMOs are
the natural source of fermentable polysaccharide for human
newborn colonizing bacteria and are therefore matched to
the selection of specific microbial species that are genetically
endowed to fully consume this prebiotic (32, 33). Accordingly,
one of the primary benefits of HBM can be viewed as
providing the needed selection pressure for health-promoting
favorable microbes like bifidobacteriae (27, 34) that carry
the necessary molecular capacity for HMO metabolism (33,
35). In the absence of favorable HMO consuming colonizers
reduced through a variety of detrimental mechanisms including
pervasive perinatal antibiotic usage in NICU hospitalized
newborns, there is a taxonomic shift in colonizing bacteria
from the obligate anaerobic phyla Bacteroidaceae and Firmicutes

with intestinal injury patterns observed in premature newborns
with NEC. Taken together, these findings implicate aberrant
colonizing microbe metabolism as the pathophysiologic
link between Proteobacteria colonization and NEC in
preterm newborns.
In the gut, colonizing bacteria compete for carbon sources
to establish their respective ecological niches. Optimization
of carbon sourcing for colonizing bacteria is dependent on
the human newborn host to provide fermentable substrate
in the form of protein and carbohydrate food substances.
The mutualism model and the provision of microbe directed
ecological services suggests the process of human newborn
gut colonization has evolved to maximize synergistic benefits
between human host and gut microbiota (31). A full 15% of
volume content of the infant’s first food substance, human
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FIGURE 6

Formate causes intestinal epithelial injury in vivo. (A) Luminal administration of formate induces intestinal epithelial injury of neonatal mice in an
age-dependent manner as 14-day mice and 28-day mice demonstrate a differential response to the same challenge (n = 8 in each group;
Paired t-test was performed). (B) H&E stain of mouse intestines that were treated with or without 150 mM of Formate (V, villus; E, epithelial cells;
M, muscle layer; L, lumen; C, crypt). (B) Histological grading scale of mouse intestinal epithelium; [unpaired t-test). Ctrl, control]. (C) Histological
grading scale of mouse intestinal epithelium; (unpaired t-test) Ctrl, control.

toward facultative anaerobic Proteobacteria that should typically
represent a minority population in newborns and health adults
(36). Thus, the ability to ferment and degrade various host dietderived carbohydrate is a major determinant of successful gut
microbial colonization but requires the presence of a capable
symbiont that might have been placed under strong de-selection
pressure through medical interventions in the NICU.
The balance among various obligate anaerobes is
dramatically disrupted in the gut of most NICU hospitalized
newborns, representing an archetype dysbiotic state with a
shift toward facultative anaerobic and over representation
of specific species within the Enterobacteraceae family (e.g.,

Frontiers in Pediatrics

Klebsiella pneumoniae, Enterobacter cloacae) (8, 10, 37, 38). This
dysbiotic state has been established as inflammation inducing
(10, 15), along with the potential for profound changes to
the metabolite milieu resulting from the alternative modes
of nutrient degradation and macromolecule fermentations
(39, 40). Indeed, several publications have shown a similar
pattern of proteobacteria predominant colonization patterns in
NICUs broadly (8, 15) and more specifically in preterm babies
developing the gut pathology of NEC (41).
The complexity of the human intestinal microbiome and
widespread dysbiosis among NICU hospitalized newborns has
confounded the search for a pathophysiologic connection
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FIGURE 7

Schematic working model of proposed novel mechanism of NEC induced by gut functional dysbiosis in human premature newborns. (1)
Functional metagenomic analysis revealed that Enterobacter cloacae and Klebsiella pneumoniae are the most discriminatory taxa related to
NEC dysbiosis, (2) These top-two species are major contributors to the KEGG ortholog KO0656, pyruvate formate lyase, which directs the
bidirectional conversion of pyruvate to Acetyl-CoA and formate. (3) PFL is up to 3-folds higher in NEC vs. control. (4) The concentration of
formate increases more than 6-folds in fecal samples of NEC patient via a key anaerobic pathway of mixed acid fermentation. (5) Excess
fermentation products including formate and gas produce epithelial cytotoxicity and the hallmark sign of pneumatosis intestinale observed in
intestinal mucosal injury in NEC. Parts enclosed in rectangular boxes are direct results from current study. LDH, Lactate dehydrogenase; PFL,
Pyruvate formate lyase; ALDH, aldehyde dehydrogenase; ADH, alcohol dehydrogenase; PTA, phosphotransacetylase; ACK, acetate kinase.

between changes in taxonomy and NEC onset (8, 15). To probe
the functional relationship between NEC and enteric dysbiosis
in premature newborns, we assembled and analyzed publicly
available metagenomic sequencing of newborns that developed
NEC and age-matched preterm newborns that did not. To
extend prior analyses we examined species level differences and
associated metabolic pathways that suggested specific alterations
conferred by the representative microbes and their functional
consequences. The functional metagenomic findings herein
strongly implicate the Enterobacteraceae species Enterobacter
cloacae and Klebsiella pneumoniae as major contributors to the
KEGG ortholog KO0656, pyruvate formate lyase, which directs
the bidirectional conversion of pyruvate to Acetyl-CoA and
formate. This biochemical mechanism connects the speciesspecific Enterobacteriaceae signature and bacterial formate
production as a plausible causative factor involved in mucosal
injury observed in NEC. Indeed, our analyses demonstrate that
these two specific microbial species that are strongly overrepresented in NEC contribute over 90% of the microbiome
contribution to that gene (Figure 7).
Indeed, machine learning models as well as classic statistical
approaches computed at different levels of the microbiome
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including taxonomy, pathways and genes, all pointed to the
same microbial signatures as the most powerful discriminatory
feature between NEC and control groups. It is apparent that
the approach presented herein of refined species-specific gene
and pathway stratification rather than the collective orthologous
functions of all microbes, provides the highest predictive power
and possible pathophysiologic resolution when considering the
role of the microbiome in NEC onset. Changes in fecal stream
metabolites represent the functional interaction of the speciesspecific microbiome, the host and enteral substrates. Organic
acids represent intermediate substrates in gut fermentation
processes with observable effects on gut fecal pH (lactate),
substrates for enterocyte fuel sources (e.g., butyric, lactic, and
acetic acid) and intermediates of microbial and host respiration.
Intriguingly, among a panel of measured common organic
acids in human newborns during NEC onset, we observed a
dramatic and significant increase in enteric formate production
as measured in the fecal stream. The meaningfulness of these
observations was reinforced by the temporal association with
NEC onset and the return to baseline of formate during NEC
resolution to levels similar to non-NEC control infants. Since
formate has been linked to microbial respiration associated with
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an expansion of Proteobacteria and enteric inflammation (19),
formate appears to fulfill criteria as a functional mediator of
intestinal injury arising from premature newborn dysbiosis.
Finally, in order to further investigate whether a lead
pathogen-derived metabolite would fit within the development
dependent toxicity model of NEC described here and previously
(25, 28), we empirically tested formate in a rodent model
of enteric injury at developmentally disparate times chosen
to mimic NEC. We found that formate indeed produces a
dose-dependent toxicity to enteric epithelia in both human
cell model(s) and pre-clinical rodent models. Taken together,
metagenome modeling and metabolic toxicity testing suggest
that a microbial signature that is highly accurate in defining NEC
onset likely represents the intersection with a susceptible and
exposed host enteric mucosa. The emerging metabolic model
of NEC presented herein implicates significant differences
in pyruvate metabolism resulting in an over-abundance and
accumulation of formate in the gut of human newborns that
temporally coincides with NEC onset and resolution. We
speculate that the emerging metabolic model of NEC herein
may accommodate the variable rates of NEC in similarly
dysbiotic newborns given variability in formate production as
a combinatorial function of intestinal transit, enteral substrate,
microbial composition, and enteric susceptibility to injury.
In conclusion, the multi-omics approach used in this
study suggests a novel mechanism of NEC onset through the
production and accumulation of enteric fermentation products,
particularly formate. This metabolic model of NEC is consistent
with and extends prior work suggesting newborn enteric
microbial community adaptation of specific members as a first
step toward the development of NEC (42). Enterobacter cloacae
and Klebsiella pneumonieae were the most discriminatory taxa
related to dysbiosis and increased formate production which
elicits a dose-dependent toxicity to enteric epithelia consistent
with NEC-like intestinal injury. These findings support ongoing
efforts to prevent NEC through the reduction of newborn gut
dysbiosis including decreasing the abundance of specific riskassociated taxa and providing possible metabolite biomarkers
for determining the effectiveness of interventions including
early-life probiotic feeding with a determination of effect on
enteric biochemical changes.

PCA matched premature newborns; (III) SCFA toxicity testing
in vitro and in vivo.

Cohort selection and data extraction
To probe the functional relationship between NEC and
enteric dysbiosis in the premature newborn, we assembled and
analyzed publicly available metagenomic sequencing data of
newborns who developed NEC along with age matched preterm
newborns that did not develop NEC. A total of eight studies
that performed shotgun metagenomic sequencing matching the
word “NEC” or “preterm” on NCBI Sequence Read Archive
(SRA) were chosen for analysis. A detailed summary of the
studies, sequencing count and patient characteristics can be
found in Supplementary Table 3. In order for a sample to be
included in the analysis a minimum of intrinsic metadata
criteria had to be met in regard to reporting “day of life,”
“NEC presence/absence,” “antibiotic treatment,” “country of
origin,” “gestational age,” “delivery mode,” “feeding practice,”
“sex,” and “birth weight.” After applying filtering criteria based
on meta data, a total of 1,647 shotgun metagenomic raw datasets
were retained. These represent every shotgun metagenomics
sequencing dataset from preterm babies available in the NCBI
SRA as of September 2019.

Feature annotation
Samples were analyzed concurrently within the same
computational pipeline. Taxonomic profiling of the
metagenomic samples was performed using MetaPhlAn2
(43) with default parameters, using the included library of cladespecific markers to provide panmicrobial (bacterial, archaeal,
viral, and eukaryotic) profiling. Functional gene characterization
was performed using the HUMAnN2 (44) pipeline with default
settings following the updated global profiling of the Human
Microbiome Project analysis pipeline (45). After MetaPhlan and
HUMAnN2 pipeline, several different matrices were obtained
containing taxonomic or functional annotations based on
different classifications against UniRef90 (46), KEGG (47), and
MetaCyc (48) databases.

Materials and methods

Data preparation and feature selection

General study design

A taxonomic relative abundance matrix created by
HUMAnN2 was obtained and a target post-conceptual
(gestational age plus postnatal day) age window was obtained
through statistical learning techniques. Random forest
models were trained to predict NEC from taxonomic relative
abundances on progressively increasing windows of PMA (full
window and shifting windows of 2, 3, 4, and 5 weeks of PMA

This study was conducted in several stages as follows: (I)
In silico aggregation and modeling of premature newborn
metagenomes in NEC and post-conceptual age-matched
newborns; (II) Determination of targeted organic acid
concentration changes in the fecal stream of NEC (cases) and
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and ages of outlying samples were filtered out). Furthermore,
false positives and false negatives from the above models were
analyzed by gestational age to reveal trends between PMA and
incorrectly classified samples. The full pipeline is outlined in
Supplementary Figure 2.

The sub list of significant proteins was further filtered
to eliminate UniRef90 ids associated with “obsolete” proteins
yielding a total of 1,815 proteins. Protein feature ranking of
UniRef90 proteins was determined by conducting recursive
feature elimination with a step of 1 on a random forest classifier.
To determine the minimum number of top ranked features
to yield high accuracy and generalizability, a random forest
classifier was trained on the top features from top 1 to top 746.
A train, test, and validation accuracy score was calculated for
each set of top ranked features. The associated taxa from these
proteins were obtained from HUMAnN2 output files and these
were analyzed to determine which species were associated with
NEC. A final random forest model was trained and ranking
conducted on these proteins stratified by species to confirm the
model and increase understandability of the previous model.
The workflow for the random forest and ranking were identical
to the first (unstratified) protein model.

Pathway identiﬁcation and ranking
through machine learning
An initial two datasets, an unstratified pathway abundance
dataset and a pathway abundance dataset stratified by bacterial
species, were divided into two groups: those with PMA < 29 and
those with PMA ≥ 29. Each of these two datasets was further
divided into four smaller datasets: a training set with original
NEC distribution (unbalanced), a training set with oversampled
NEC distribution (balanced), a testing set (20%) of unique
samples, and a validation set (20%) of unique samples. For each
training dataset, a Gradient Boosting Classifier from python’s
scikit-learn library was trained to classify each sample as NEC
or non-NEC. Hyperparameters were grid-searched for each
dataset and the model with highest specificity and sensitivity was
selected for further analysis.
Feature importance was calculated from the highest
performing hyperparameters using Gini importance scores.
Because Gini importance scores account for the impurity at
each node, these scores were expected to change significantly
between the balanced and unbalanced datasets. Thus, to
confirm findings from feature importance scores, ranking was
also conducted. Pathway feature ranking was determined by
conducting recursive feature elimination with a step of 50 on a
random forest classifier. Subsequently, the top 500 features were
ranked implementing recursive feature elimination on the same
model with a step size of 1.

Short chain fatty acids (SCFAs) analysis
Twenty-four fecal specimens were collected from 10 nonill age-matched premature newborns and 3 patients with
NEC, 8 stools at disease onset and 6 stools during recovery
and after 3 weeks’ clinical treatment. A panel of SCFAs
(Table 1) were quantified using Agilent 6490 triple quadruple
mass spectrometer following extraction from fecal samples as
previously described (49). Briefly, samples were diluted with
80% ethanol (10 µl/mg) and gently agitated overnight at
4◦ C. The homogenized samples were centrifuged at 21,000
× g for 5 min. 200 µl of the supernatants were transferred
centrifuged at 21,000 × g again for 20 min. For each sample,
20 µl of the supernatant was mixed with 20 µl of 200 mM N(3-Dimethylaminopropyl)-N′ -ethylcarbodiimide hydrochloride
(1-EDC HCl) (SIGMA) in 5% pyridine (SIGMA) and 40 uL
of 100 mM 2-Nitrophenylhydrazine (2-NPH) (SIGMA) in 80%
acetonitrile (ACN) (SIGMA) with 50 mM HCl. The mixture was
incubated at 40◦ C for 30 min. After reacting, 400 µl of 10%
ACN was added to the solution. Then 1 µl the solution was
injected into an Agilent 6490 triple quadruple mass spectrometer
for analysis.

Statistical analysis and ranking of 90%
identity proteins
Significantly different genes among groups were estimated
using the Kruskal–Wallis one-way analysis of variance,
coupled with FDR or Bonferroni correction as cross-sample
normalization. A Bray-Curtis dissimilarity matrix was
constructed to estimate global differences among samples
and visualized via Principal Coordinate Analysis (PCoA).
Permutational Multivariate Analysis of Variance Using Distance
Matrices (adonis) was used to assess global microbiome
differences between treatments and the effect-size (R2 ) of
disease status on the microbiome composition P-value for
PCoA panel was computed using F-tests based on sequential
sums of squares from permutations of the raw data. P-values
throughout the manuscript are represented by asterisks (∗ P <
0.05; ∗∗ P < 0.01; ∗∗∗ P < 0.001; ∗∗∗∗ P < 0.0001).
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Cell culture assays
The human intestinal epithelial cell line (HIEC-6) was
acquired from the American Type Culture Collection (ATCC,
Manassas, VA, USA) and cultured in opti-MEM medium
(Gibco) with 4% FBS (Gibco), 10 ng/mLEGF (Gibco), and 1%
penicillin-streptomycin. Small intestinal samples were obtained
fresh from the Surgical Pathology Department of Stanford
University. The 24-well Transwell inserts (Corning 3414) were
coated with collagen IV (30 µg/mL) and incubated in 37◦ C
for 2 h to ensure successful coating. The enteroids containing
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Matrigel buttons were scraped off from the tissue culture plate
and disassociated into single cells. Cell containing solutions were
then pass through 40 µm cell strainer before centrifuging at
1,000 rpm for 5 min. Cell pellets were resuspended with enteroid
culture media supplemented with Y-inhibitor and CHIR-99021,
and previously described (50, 51) and seeded onto the apical side
of the collagen IV coated Transwell inserts at a density of 750
k/cm2. Monolayers were then cultured in enteroid culture media
for 5 d with media changes every 2 d. On day 5, the culture media
was switched to differentiation media for 4 d to induce cellular
differentiation. The differentiation media was enteroid culture
media in the absence of Wnt3a, r-spondin, Nicotinamide and
SB-202190. Upon withdrawal of these factors, the proliferative
cell lineage is noted to differentiate into a secretory cell lineage
(50–57). All cells were cultured in an incubator maintained with
5% CO2 at 37◦ C.
HIEC-6 Cells (1 × 105 /well) were treated with Sodium
Formate (Formate) (0, 17, 50, 150 mM) in 48-well plates and
stained with Trypan blue solution after 0.5, 1.5, 6, 24, 48, 72 h.

Instruments; Sarasota, FL). Monolayers were prepared from
differentiated primary small intestine stem cells and cultured in
24-well Transwell inserts prior to treatment with formate (0, 17,
50, 150 mM) at the basolateral side of the monolayer. The TEER
measurement was performed at the indicated time points after
formate treatment.

In vivo NEC mouse model
FVB/N mice aged 14 d or 28 d (n = 20/group) were chosen
to mimic human newborns and infants for comparation of
their response to intraluminal formate challenge. The mouse
abdomen was entered via midline laparotomy with a 1.5 cm
incision. After exposure of the ileocecal junction, a sterile
solution of sodium formate (150 mM, 10 ul/g body weight) was
injected directly into the intestinal lumen using a 27G needle
toward the proximal direction. The abdominal wall was closed in
layers using 4-0 vicryl suture. Stool sample pellets were collected
individually for 24 h and stored at −80◦ C. After 24 h, mice
were sacrificed, and small intestines harvested and stored either
at −80◦ C or formalin-fixed. All experiments were conducted
under a protocol approved by Stanford University School of
Medicine Institutional Animal Care and in accordance with
NIH guidelines.

Cell toxicity and survival assessment
The percentage of surviving cells was calculated as follow.
HIEC-6 cells (1 × 105 /well- 24 well plate) were seeded and
maintained as above. After 70% confluence, the cells were treated
with Formate (0, 17, 50, 150 mM). After 24, 48, and 72 h of
incubation, 50 µl of the supernatant was collected in triplicate
to a 96-well plate and stored in −20◦ C refrigerator for LDH
assay. 50 µl of 2% NP40 were added to each well of the 96well plate, mixed with the supernatant and incubated at room
temperature with shaking for 15 min. One hundred microliter
of the Cytotoxicity Detection Kit LDH solution (Takara, Japan)
was added to each well. After 15 min of incubation at room
temperature in the dark, the OD value was measured at 492 nm
in a SpectraMax R i3x multi-mode microplate reader (Molecular
Devices, LCC. CA, USA) (620 nm as reference).
The CellTiter-Glo R 2.0 reagent was used for determination
of ATP content according to the manufacturer’s instructions (for
G9242 from Promega Biotechnology Company, Madison, WI).
Briefly, 100 µl of CellTiter-Glo R 2.0 Reagent were added to each
well. The contents were mixed for 2 min on an orbital shaker
to induce cell lysis, followed by incubation at room temperature
for 10 min to stabilize the luminescent signal. The plates were
read using the SpectraMax R i3x multi-mode microplate reader
(Molecular Devices, LCC. CA, USA).

Histological analysis
Intestinal tissues were fixed in 4% paraformaldehyde,
embedded in paraffin and 8 µm thick sections were stained with
hematoxylin-eosin (H&E) (ScyTek Laboratories, Inc., Logan,
UT, USA) according to a standard protocol.

Evaluation of intestinal injury
A modified ELISA was used to measure the insoluble protein
cytokeratin 8 (K8) in stool from both human and mice. Briefly,
96-well MaxiSorpTM Nunc-immuno module plates (Thermo
Fisher Scientific) were pre-coated with protein K8 overnight
at 4◦ C. Twenty five microliter of diluted fecal samples and
standards were mixed with 25 µl blocking buffer (5% skim
milk/PBST/2% NP40) for 30 min with shaking. Fifty microliter
anti-K8 antibody (MilliporeSigma, USA) was added to each
well and incubated at RT for 1 h with shaking. The mixed
samples with antibody were transferred to pre-coated plates and
incubated for 1 h at RT with shaking (100 µl/well), followed
by washing 3 times in PBST buffer. Hundred microliter HRP
(horseradish peroxidase)-conjugated goat anti-rat antibodies
(Immnuoreagents lnc.) was added, followed by standard ELISA
procedures. The plates were read at 450 nm with reference
filter at 620 nm using the SpectraMax R i3x multi-mode

Transepithelial electrical resistance
(TEER) assay
To examine the effect of formate on human intestinal
epithelial monolayer permeability, TEER was measured
using a EVOM2 Epithelial Voltohmmeter (World Precision
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microplate reader (Molecular Devices, LCC. CA, USA). Final
concentrations were obtained using the standard curve method.

Western blot analysis
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polyvinylidene difluoride membranes (Amersham Biosciences,
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Statistical analysis of in vitro and in vivo
empirical testing
Data are presented as means ± SD and statistical analysis
was performed using Student’s t test (SPSS Statistics, version
19.0, Chicago). P < 0.05 was considered statistically significant.
The data graphs were made with GraphPad Prism 5.0 software
(Graph-Pad Software, CA, USA).

Supplementary material

Data availability statement

The Supplementary Material for this article can be
found online at: https://www.frontiersin.org/articles/10.3389/
fped.2022.893059/full#supplementary-material

The original contributions presented in the study are
included in the article/Supplementary material, further inquiries
can be directed to the corresponding author/s.

SUPPLEMENTARY FIGURE 1

Plot of taxonomy model test sensitivity (y-axis) according to PMA
(x-axis) (post menstrual age). The week group refers to the range of ages
used to train the model(s).

Ethics statement

SUPPLEMENTARY FIGURE 2

Schematic of the metagenomic data modeling strategy.

The animal study was reviewed and approved by Stanford
University School of Medicine Institutional Animal Care.

SUPPLEMENTARY FIGURE 3

Western blot showing relevant protein effector protein changes in dose
response to formate by HIEC-6 cells (human intestinal epithelial cells 6).
(mM = milli-molar), AKT = protein kinase B) [pMLKL = phospho-mixed
lineage kinase domain-like protein (MLKL) (PGC1a = peroxisome
proliferator-activated receptor gamma coactivator)-1alpha].

Author contributions

SUPPLEMENTARY TABLE 1

GC, SF, BH, and KS conceived the study. GC, SF, BH, GZT, JW, and KS designed the study. JW, JL, KW, G-ZT, and

Frontiers in Pediatrics

Relative abundance of species by sample displayed such that each
sample sums to 1.

15

frontiersin.org

Casaburi et al.

10.3389/fped.2022.893059

SUPPLEMENTARY TABLE 2

SUPPLEMENTARY TABLE 3

Histological grading scale for neonatal mouse model of
NEC.

Sample metadata from publicly available datasets combined into
single sheet.

References
1. Boghossian NS, Geraci M, Edwards EM, Horbar JD. Morbidity and mortality
in small for gestational age infants at 22 to 29 weeks’ gestation. Pediatrics. (2017)
141:e20172533. doi: 10.1542/peds.2017-2533

18. Polari L, Alam CM, Nyström JH, Heikkilä T, Tayyab M, Baghestani
S, et al. Keratin intermediate filaments in the colon: guardians of epithelial
homeostasis. Int J Biochem Cell Biol. (2020) 129:105878. doi: 10.1016/j.biocel.2020.
105878

2. Horbar JD, Badger GJ, Carpenter JH, Fanaroff AA, Kilpatrick S, LaCorte
M, et al. Trends in Mortality and morbidity for very low birth weight infants,
1991–1999. Pediatrics. (2002) 110:143–51. doi: 10.1542/peds.110.1.143

19. Hughes ER, Winter MG, Duerkop BA, Spiga L, de Carvalho TF,
Zhu W, et al. Microbial respiration and formate oxidation as metabolic
signatures of inflammation-associated dysbiosis. Cell Host Microbe. (2017) 21:208–
19. doi: 10.1016/j.chom.2017.01.005

3. Horbar JD, Carpenter JH, Badger GJ, Kenny MJ, Soll RF, Morrow KA, et al.
Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to
2009. Pediatrics. (2012) 129:1019–26. doi: 10.1542/peds.2011-3028

20. Du L, Su Y, Sun D, Zhu W, Wang J, Zhuang X, et al. Formic acid
induces Yca1p-independent apoptosis-like cell death in the yeast Saccharomyces
cerevisiae. Fems Yeast Res. (2008) 8:531–9. doi: 10.1111/j.1567-1364.2008.
00375.x

4. Gephart SM, Gordon PV, Penn AH, Gregory KE, Swanson JR, Maheshwari
A, et al. Changing the paradigm of defining, detecting, and diagnosing NEC:
perspectives on Bell’s stages and biomarkers for NEC. Semin Pediatr Surg. (2018)
27:3–10. doi: 10.1053/j.sempedsurg.2017.11.002

21. Nicholls P. Formate as an inhibitor of cytochrome c oxidase. Biochem
Biophys Res Commun. (1975) 67:610–6. doi: 10.1016/0006-291X(75)90
856-6

5. Pammi M, Cope J, Tarr PI, Warner BB, Morrow AL, Mai V, et al. Intestinal
dysbiosis in preterm infants preceding necrotizing enterocolitis: a systematic
review and meta-analysis. (2017) 5:31. doi: 10.1186/s40168-017-0248-8

22. Bein A, Eventov-Friedman S, Arbell D, Schwartz B. Intestinal tight junctions
are severely altered in NEC preterm neonates. Pediatr Neonatol. (2018) 59:464–
73. doi: 10.1016/j.pedneo.2017.11.018

6. He Y, Du W, Xiao S, Zeng B, She X, Liu D, et al. Colonization of fecal
microbiota from patients with neonatal necrotizing enterocolitis exacerbates
intestinal injury in germfree mice subjected to necrotizing enterocolitis-induction
protocol via alterations in butyrate and regulatory T cells. J Transl Med. (2021)
19:510. doi: 10.1186/s12967-021-03109-5

23. Halpern MD, Denning PW. The role of intestinal epithelial barrier
function in the development of NEC. Tissue Barriers. (2015) 3:e1000707–
10. doi: 10.1080/21688370.2014.1000707

7. Roy SK, Meng Q, Sadowitz BD, Kollisch-Singule M, Yepuri N, Satalin J,
et al. Enteral administration of bacteria fermented formula in newborn piglets:
a high fidelity model for necrotizing enterocolitis (NEC). PLoS ONE. (2018)
13:e0201172. doi: 10.1371/journal.pone.0201172

24. Negroni A, Colantoni E, Pierdomenico M, Palone F, Costanzo M, Oliva
S, et al. RIP3 AND pMLKL promote necroptosis-induced inflammation and
alter membrane permeability in intestinal epithelial cells. Dig Liver Dis. (2017)
49:1201–10. doi: 10.1016/j.dld.2017.08.017

8. Brooks B, Olm MR, Firek BA, Baker R, Thomas BC, Morowitz
MJ, et al. Strain-resolved analysis of hospital rooms and infants reveals
overlap between the human and room microbiome. Nat Commun. (2017)
8:1814. doi: 10.1038/s41467-017-02018-w

25. Werts AD, Fulton WB, Ladd MR, Saad-Eldin A, Chen YX, Kovler ML, et al.
A novel role for necroptosis in the pathogenesis of necrotizing enterocolitis. Cell
Mol Gastroenterol Hepatol. (2020) 9:403–23. doi: 10.1016/j.jcmgh.2019.11.002
26. Elgin TG, Kern SL, McElroy SJ. Development of the neonatal intestinal
microbiome and its association with necrotizing enterocolitis. Clin Ther. (2016)
38:706–15. doi: 10.1016/j.clinthera.2016.01.005

9. Gibson MK, Wang B, Ahmadi S, Burnham CAD, Tarr PI, Warner BB, et al.
Developmental dynamics of the preterm infant gut microbiota and antibiotic
resistome. Nat Microbiol. (2016) 1:16024. doi: 10.1038/nmicrobiol.2016.24
10. Ho TTB, Groer MW, Kane B, Yee AL, Torres BA, Gilbert JA, Maheshwari
A. Enteric dysbiosis and fecal calprotectin expression in premature infants. Pediatr
Res. (2019) 85:361–8. doi: 10.1038/s41390-018-0254-y

27. Ling X, Linglong P, Weixia D, Hong W. Protective effects of
bifidobacterium on intestinal barrier function in LPS-induced enterocyte
barrier injury of Caco-2 monolayers and in a rat NEC model. PLoS ONE. (2016)
11:e0161635. doi: 10.1371/journal.pone.0161635

11. Warner BB, Deych E, Zhou Y, Hall-Moore C, Weinstock GM, Sodergren
E, et al. Gut bacteria dysbiosis and necrotising enterocolitis in very low
birthweight infants: a prospective case-control study. Lancet. (2016) 387:1928–
36. doi: 10.1016/S0140-6736(16)00081-7

28. Lu P, Sodhi CP, Jia H, Shaffiey S, Good M, Branca MF, et al. Animal models
of gastrointestinal and liver diseases. Animal models of necrotizing enterocolitis:
pathophysiology, translational relevance, and challenges. Am J Physiol Gastrointest
Liver Physiol. (2014) 306:G917–28. doi: 10.1152/ajpgi.00422.2013

12. Milani C, Duranti S, Bottacini F, Casey E, Turroni F, Mahony J, et al.
The first microbial colonizers of the human gut: composition, activities, and
health implications of the infant gut microbiota. Microbiol Mol Biol Rev. (2017)
81:e00036–17. doi: 10.1128/MMBR.00036-17

29. Xing T, Salazar RC, Chen Y-H. Animal models for studying epithelial barriers
in neonatal necrotizing enterocolitis, inflammatory bowel disease and colorectal
cancer. Tissue Barriers. (2017) 5:e1356901. doi: 10.1080/21688370.2017.1356901
30. McElroy SJ, Castle SL, Bernard JK, Almohazey D, Hunter CJ, Bell BA,
et al. The ErbB4 Ligand Neuregulin-4 protects against experimental necrotizing
enterocolitis. Am J Pathol. (2014) 184:2768–78. doi: 10.1016/j.ajpath.2014.06.015

13. Raveh-Sadka T, Firek B, Sharon I, Baker R, Brown CT, Thomas BC, et al.
Evidence for persistent and shared bacterial strains against a background of
largely unique gut colonization in hospitalized premature infants. ISME J. (2016)
10:2817–30. doi: 10.1038/ismej.2016.83

31. Duar RM, Henrick BM, Casaburi G, Frese SA. Integrating the ecosystem
services framework to define dysbiosis of the breastfed infant gut: the
role of infantis B, and Human Milk Oligosaccharides. Front Nutr. (2020)
7:33. doi: 10.3389/fnut.2020.00033

14. Casaburi G, Duar RM, Vance DP, Mitchell R, Contreras L, Frese
SA, et al. Early-life gut microbiome modulation reduces the abundance
of antibiotic- resistant bacteria. Antimicrob Resist Infect Control. (2019)
8:131. doi: 10.1186/s13756-019-0583-6

32. LoCascio RG, Niñonuevo MR, Freeman SL, Sela DA, Grimm R, Lebrilla
CB, et al. Glycoprofiling of bifidobacterial consumption of human milk
oligosaccharides demonstrates strain specific, preferential consumption of small
chain glycans secreted in early human lactation. J Agric Food Chem. (2007)
55:8914–9. doi: 10.1021/jf0710480

15. Nguyen M, Holdbrooks H, Mishra P, Abrantes MA, Eskew S, Garma M, et al.
Impact of probiotic B. infantis EVC001 feeding in premature infants on the gut
microbiome, nosocomially acquired antibiotic resistance, enteric inflammation.
Front Pediatr. (2021) 9:618009. doi: 10.3389/fped.2021.618009

33. Sela DA, Chapman J, Adeuya A, Kim JH, Chen F, Whitehead TR, et al. The
genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations
for milk utilization within the infant microbiome. Proc Natl Acad Sci. (2008)
105:18964–9. doi: 10.1073/pnas.0809584105

16. Olm MR, Bhattacharya N, Crits-Christoph A, Firek BA, Baker R,
Song YS, et al. Necrotizing enterocolitis is preceded by increased gut
bacterial replication, Klebsiella, fimbriae-encoding bacteria. Sci Adv. (2019)
5:eaax5727. doi: 10.1126/sciadv.aax5727

34. Khailova L, Dvorak K, Arganbright KM, Halpern MD, Kinouchi T, Yajima
M, et al. Bifidobacterium bifidum improves intestinal integrity in a rat model of
necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol. (2009) 297:G940–
9. doi: 10.1152/ajpgi.00141.2009

17. Casaburi G, Frese SA. Colonization of breastfed infants by Bifidobacterium
longum subsp. infantis EVC001 reduces virulence gene abundance. Hum
Microbiome J. (2018) 9:7–10. doi: 10.1016/j.humic.2018.05.001

Frontiers in Pediatrics

16

frontiersin.org

Casaburi et al.

10.3389/fped.2022.893059

47. Kanehisa M, Goto S, KEGG: Kyoto Encyclopedia of Genes
and Genomes. Nucleic Acids Res. (2000) 28:27–30. doi: 10.1093/nar/
28.1.27

35. Garrido D, Ruiz-Moyano S, Lemay DG, Sela DA, German JB, Mills DA.
Comparative transcriptomics reveals key differences in the response to milk
oligosaccharides of infant gut-associated bifidobacteria. Nat Publishing Group.
(2015) 1–18. doi: 10.1038/srep13517

48. Caspi R, Foerster H, Fulcher CA, Kaipa P, Krummenacker M, Latendresse M,
et al. The MetaCyc Database of metabolic pathways and enzymes and the BioCyc
collection of Pathway/Genome Databases. Nucleic Acids Res. (2008) 36:D623–
31. doi: 10.1093/nar/gkm900

36. Shin N-R, Whon TW, Bae J-W. Proteobacteria: microbial
signature of dysbiosis in gut microbiota. Trends Biotechnol. (2019)
33:496–503. doi: 10.1016/j.tibtech.2015.06.011
37. Groer MW, Luciano AA, Dishaw LJ, Ashmeade TL, Miller E, Gilbert
JA. Development of the preterm infant gut microbiome: a research priority.
Microbiome. (2014) 2:38. doi: 10.1186/2049-2618-2-38

49. Frese SA, Hutton AA, Contreras LN, Shaw CA, Palumbo MC, Casaburi G,
et al. Persistence of supplemented Bifidobacterium longum subsp. infantis EVC001
in Breastfed Infants. mSphere. (2017) 2:e00501–17. doi: 10.1128/mSphere.00
501-17

38. Yee AL, Miller E, Dishaw LJ, Gordon JM, Ji M, Dutra S, et al.
Longitudinal microbiome composition and stability correlate with increased
weight and length of very-low-birth-weight infants. mSystems. (2019) 4:e00229–
18. doi: 10.1128/mSystems.00229-18

50. Sato T, Stange DE, Ferrante M, Vries RG, Van Es JH, Van
den Brink S, et al. Long-term expansion of epithelial organoids
from human colon, adenoma, adenocarcinoma, barrett’s epithelium.
Gastroenterology.
(2011)
141:1762–72.
doi:
10.1053/j.gastro.2011.
07.050

39. Alcon-Giner C, Dalby MJ, Caim S, Ketskemety J, Shaw A, Sim K, et al.
Microbiota supplementation with Bifidobacterium and Lactobacillus modifies the
preterm infant gut microbiota and metabolome: an observational study. Cell Rep
Med. (2020) 1:100077. doi: 10.1016/j.xcrm.2020.100077

51. Scott A, Rouch JD, Jabaji Z, Khalil HA, Solorzano S, Lewis M, et al. Longterm renewable human intestinal epithelial stem cells as monolayers: a potential
for clinical use. J Pediatr Surg. (2016) 51:995–1000. doi: 10.1016/j.jpedsurg.2016.
02.074

40. Stewart CJ, Embleton ND, Marrs ECL, Smith DP, Fofanova T, Nelson
A, et al. Longitudinal development of the gut microbiome and metabolome in
preterm neonates with late onset sepsis and healthy controls. Microbiome. (2017)
5:75. doi: 10.1186/s40168-017-0295-1

52. In J, Foulke-Abel J, Zachos NC, Hansen A-M, Kaper JB, Bernstein HD, et al.
Enterohemorrhagic Escherichia coli reduces Mucus and Intermicrovillar Bridges
in human stem cell-derived colonoids. Cell Mol Gastroenterol Hepatol. (2016)
2:48–62.e3. doi: 10.1016/j.jcmgh.2015.10.001

41. Morrow AL, Lagomarcino AJ, Schibler KR, Taft DH, Yu Z, Wang
B, et al. Early microbial and metabolomic signatures predict later onset
of necrotizing enterocolitis in preterm infants. Microbiome. (2013)
1:13. doi: 10.1186/2049-2618-1-13

53. Jung P, Sato T, Merlos-Suárez A, Barriga FM, Iglesias M, Rossell D, et al.
Isolation and in vitro expansion of human colonic stem cells. Nat Med. (2011)
17:1225–7. doi: 10.1038/nm.2470

42. Claud EC, Keegan KP, Brulc JM, Lu L, Bartels D, Glass E, et al.
Bacterial community structure and functional contributions to emergence of
health or necrotizing enterocolitis in preterm infants. Microbiome. (2013)
1:20. doi: 10.1186/2049-2618-1-20

54. Kasendra M, Tovaglieri A, Sontheimer-Phelps A, Jalili-Firoozinezhad
S, Bein A, Chalkiadaki A, et al. Development of a primary human Small
Intestine-on-a-Chip using biopsy-derived organoids. Sci Rep. (2018)
8:2871. doi: 10.1038/s41598-018-21201-7

43. Truong DT, Franzosa EA, Tickle TL, Scholz M, Weingart G, Pasolli E, et al.
MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat Methods. (2015)
12:902–3. doi: 10.1038/nmeth.3589

55. Moon C, VanDussen KL, Miyoshi H, Stappenbeck TS. Development
of a primary mouse intestinal epithelial cell monolayer culture system to
evaluate factors that modulate IgA transcytosis. Mucosal Immunol. (2014) 7:818–
28. doi: 10.1038/mi.2013.98

44. Truong DT, Tett A, Pasolli E, Huttenhower C, Segata N. Microbial strainlevel population structure and genetic diversity from metagenomes. Genome Res.
(2017) 27:626–38. doi: 10.1101/gr.216242.116
45. Lloyd-Price J, Mahurkar A, Rahnavard G, Crabtree J, Orvis J, Hall AB, et
al. Strains, functions and dynamics in the expanded human microbiome project.
Nature. (2017) 550:61–6. doi: 10.1038/nature23889

56. Noel G, Baetz NW, Staab JF, Donowitz M, Kovbasnjuk O, Pasetti MF,
et al. A primary human macrophage-enteroid co-culture model to investigate
mucosal gut physiology and host-pathogen interactions. Sci Rep. (2017)
7:45270. doi: 10.1038/srep45270

46. Apweiler R, Bairoch A, Wu CH, Barker WC, Boeckmann B, Ferro S,
et al. UniProt: the universal protein knowledgebase. Nucleic Acids Res. (2004)
32:D115–9. doi: 10.1093/nar/gkh131

57. Sato T, Clevers H. Growing self-organizing mini-guts from a single
intestinal stem cell: mechanism and applications. Science. (2013) 340:1190–
4. doi: 10.1126/science.1234852

Frontiers in Pediatrics

17

frontiersin.org

